FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2739492026> ?p ?o ?g. }

• W2739492026 endingPage "4119" @default.
• W2739492026 startingPage "4119" @default.
• W2739492026 abstract "Abstract EGFR resistant mutation, T790M, in lung adenocarcinoma is acquired through a specific cytosine deamination mechanism. Background: Epidermal growth factor receptor (EGFR) activation mutations occur in 15% of lung adenocarcinomas. This leads to constitutive activation of EGFR, which triggers multiple downstream survival and proliferation pathways. Currently, EGFR tyrosine kinase inhibitors (TKIs) are first line therapy for stage IV non-small cell lung cancer (NSCLC) patients with EGFR mutations. Despite initial significant response to TKIs, most tumors develop resistance. The main mechanism of resistance detected in 50-60% of cases is a cytosine to thymine (C&gt;T) single nucleotide transition mutation at position 2369. This causes a threonine to methionine amino acid change at position 790 (i.e. T790M). Our data suggests that the C&gt;T mutation is an acquired event secondary to cytosine deamination by Activation Induced Cytosine Deamination enzyme (AICDA). Results: Single cell clones of lung adenocarcinoma cell line, PC9, were treated with EGFR TKI. At baseline, these clones have EGFR exon 19 deletion but no evidence of T790M mutation by digital droplet PCR (ddPCR). However, after treatment with a serial increasing dose of EGFR TKI, T790M mutation was detected by ddPCR. Assessing whether cytosine deamination enzymes were altered by this treatment, a significant increase in AICDA expression was seen. Furthermore, recombinant AICDA protein could deaminate cytosine at position 2369 in vitro. In addition, using mass spectrometry and methylation specific primers, we determined that cytosine at position 2369 is in fact methylated. This further supports our hypothesis since 5-methyl cytosine is deaminated into thymine directly. Since in germinal center B-lymphocytes, AICDA is activated through a non-canonical NFkB mechanism, we assessed NFkB pathway in PC9 cell line. RelB and p52 expression were significantly increased after TKI treatment. In addition direct interaction between RelB and AICDA promoter was confirmed by ChIP Assay. These findings were also seen in a mouse PC9 xenograft model. Daily oral gavage of EGFR TKI caused significant increase in the expression of RelB as well as AICDA. Adding NFkB inhibitor twice weekly inhibited the expression of RelB and AICDA. Finally, knocking down AICDA by shRNA prevented the development of T790M mutation in PC9 cell lines after TKI exposure. Conclusion: Our data suggest that the T790M mutation could be actively acquired after TKI treatment through a cytosine deamination process by AICDA. This would have significant implications for treatment with targeted therapy. In fact, Imatinib resistance in CML and GIST tumors have a similar C&gt;T single nucleotide transition mutation. Citation Format: Khaled Hassan, Najwa El Kadi, April Davis, Gregory Kalemkerian, Luo Wang, Hasan Korkaya. The development of EGFR resistant mutation, T790M, in lung adenocarcinoma is acquired through a specific cytosine deamination mechanism [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4119. doi:10.1158/1538-7445.AM2017-4119" @default.
• W2739492026 created "2017-08-08" @default.
• W2739492026 creator A5017665917 @default.
• W2739492026 creator A5026907821 @default.
• W2739492026 creator A5031319811 @default.
• W2739492026 creator A5037279132 @default.
• W2739492026 creator A5056827435 @default.
• W2739492026 creator A5066306817 @default.
• W2739492026 date "2017-07-01" @default.
• W2739492026 modified "2023-10-12" @default.
• W2739492026 title "Abstract 4119: The development of EGFR resistant mutation, T790M, in lung adenocarcinoma is acquired through a specific cytosine deamination mechanism" @default.
• W2739492026 doi "https://doi.org/10.1158/1538-7445.am2017-4119" @default.
• W2739492026 hasPublicationYear "2017" @default.
• W2739492026 type Work @default.
• W2739492026 sameAs 2739492026 @default.
• W2739492026 citedByCount "1" @default.
• W2739492026 countsByYear W27394920262020 @default.
• W2739492026 crossrefType "journal-article" @default.
• W2739492026 hasAuthorship W2739492026A5017665917 @default.
• W2739492026 hasAuthorship W2739492026A5026907821 @default.
• W2739492026 hasAuthorship W2739492026A5031319811 @default.
• W2739492026 hasAuthorship W2739492026A5037279132 @default.
• W2739492026 hasAuthorship W2739492026A5056827435 @default.
• W2739492026 hasAuthorship W2739492026A5066306817 @default.
• W2739492026 hasConcept C104317684 @default.
• W2739492026 hasConcept C121608353 @default.
• W2739492026 hasConcept C128526571 @default.
• W2739492026 hasConcept C145782189 @default.
• W2739492026 hasConcept C153911025 @default.
• W2739492026 hasConcept C159654299 @default.
• W2739492026 hasConcept C181199279 @default.
• W2739492026 hasConcept C27082348 @default.
• W2739492026 hasConcept C2776023528 @default.
• W2739492026 hasConcept C2777930144 @default.
• W2739492026 hasConcept C2778453870 @default.
• W2739492026 hasConcept C2779438470 @default.
• W2739492026 hasConcept C2780580887 @default.
• W2739492026 hasConcept C2781182431 @default.
• W2739492026 hasConcept C501734568 @default.
• W2739492026 hasConcept C502942594 @default.
• W2739492026 hasConcept C54355233 @default.
• W2739492026 hasConcept C552990157 @default.
• W2739492026 hasConcept C55493867 @default.
• W2739492026 hasConcept C86803240 @default.
• W2739492026 hasConceptScore W2739492026C104317684 @default.
• W2739492026 hasConceptScore W2739492026C121608353 @default.
• W2739492026 hasConceptScore W2739492026C128526571 @default.
• W2739492026 hasConceptScore W2739492026C145782189 @default.
• W2739492026 hasConceptScore W2739492026C153911025 @default.
• W2739492026 hasConceptScore W2739492026C159654299 @default.
• W2739492026 hasConceptScore W2739492026C181199279 @default.
• W2739492026 hasConceptScore W2739492026C27082348 @default.
• W2739492026 hasConceptScore W2739492026C2776023528 @default.
• W2739492026 hasConceptScore W2739492026C2777930144 @default.
• W2739492026 hasConceptScore W2739492026C2778453870 @default.
• W2739492026 hasConceptScore W2739492026C2779438470 @default.
• W2739492026 hasConceptScore W2739492026C2780580887 @default.
• W2739492026 hasConceptScore W2739492026C2781182431 @default.
• W2739492026 hasConceptScore W2739492026C501734568 @default.
• W2739492026 hasConceptScore W2739492026C502942594 @default.
• W2739492026 hasConceptScore W2739492026C54355233 @default.
• W2739492026 hasConceptScore W2739492026C552990157 @default.
• W2739492026 hasConceptScore W2739492026C55493867 @default.
• W2739492026 hasConceptScore W2739492026C86803240 @default.
• W2739492026 hasIssue "13_Supplement" @default.
• W2739492026 hasLocation W27394920261 @default.
• W2739492026 hasOpenAccess W2739492026 @default.
• W2739492026 hasPrimaryLocation W27394920261 @default.
• W2739492026 hasRelatedWork W1277272224 @default.
• W2739492026 hasRelatedWork W2000268209 @default.
• W2739492026 hasRelatedWork W2119351872 @default.
• W2739492026 hasRelatedWork W2549506770 @default.
• W2739492026 hasRelatedWork W2574486063 @default.
• W2739492026 hasRelatedWork W2739492026 @default.
• W2739492026 hasRelatedWork W2754692309 @default.
• W2739492026 hasRelatedWork W2767828237 @default.
• W2739492026 hasRelatedWork W2972608234 @default.
• W2739492026 hasRelatedWork W2178238686 @default.
• W2739492026 hasVolume "77" @default.
• W2739492026 isParatext "false" @default.
• W2739492026 isRetracted "false" @default.
• W2739492026 magId "2739492026" @default.
• W2739492026 workType "article" @default.